Virax Biolabs VRAX
NASDAQ VRAX
$3.19 -0.26 (-7.54%)
At close: Aug 21, 2026 · 4:00 PM EDT

Virax Biolabs (VRAX) Cash & Equivalents Growth (3y) (2024 - 2026)

Virax Biolabs (VRAX) Cash & Equivalents Growth (3y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -15.41%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 8.23%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 47.78%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -23.18%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 14.34%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 37.45%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -14.22%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -3.85%
9 Royalty Pharma 27.27 Bn 26.43 Bn - -27.97%
10 Virax Biolabs 1.31 Mn -5.13 Mn - -11.70%

Historic Data

Download Data
DateValue
Mar 31, 2026 -11.70%
Mar 31, 2025 479.27%
Mar 31, 2024 488.38%